Compounds > ursodeoxycholic acid
Page last updated: 2024-08-23

ursodeoxycholic acid and Clostridioides difficile Infection

ursodeoxycholic acid has been researched along with Clostridioides difficile Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Melnyk, RA; Pike, CM; Tam, J; Theriot, CM1
Cai, J; Montgomery, SA; Patterson, AD; Rivera, AJ; Thanissery, R; Theriot, CM; Winston, JA1
Brunner, A; Ford, CD; Lewis, J; Lopansri, BK; Webb, BJ1
Chen, C; Dosa, PI; Graiziger, CT; Johnson, JR; Khoruts, A; Sadowsky, MJ; Shaughnessy, MK; Steer, CJ; Weingarden, AR; Zhang, N1

Other Studies

4 other study(ies) available for ursodeoxycholic acid and Clostridioides difficile Infection

ArticleYear
Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.
    Infection and immunity, 2022, 08-18, Volume: 90, Issue:8

    Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Apoptosis; Bile Acids and Salts; Caco-2 Cells; Clostridioides difficile; Clostridium Infections; Humans; Inflammation; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid

2022
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.
    Infection and immunity, 2020, 05-20, Volume: 88, Issue:6

    Topics: Animals; Bile Acids and Salts; Biomarkers; Clostridioides difficile; Clostridium Infections; Computational Biology; Dose-Response Relationship, Drug; Fibroblast Growth Factors; Fragile X Mental Retardation Protein; Gastrointestinal Microbiome; Gene Expression Profiling; Host-Pathogen Interactions; Humans; Life Cycle Stages; Mice; Signal Transduction; Transcriptome; Ursodeoxycholic Acid

2020
Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 01-18, Volume: 68, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cholagogues and Choleretics; Clostridium Infections; Drug Repositioning; Female; Humans; Male; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome; Ursodeoxycholic Acid; Young Adult

2019
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.
    Journal of clinical gastroenterology, 2016, Volume: 50, Issue:8

    Topics: Bile Acids and Salts; Clostridioides difficile; Clostridium Infections; Fecal Microbiota Transplantation; Feces; Female; Humans; In Vitro Techniques; Middle Aged; Pouchitis; Recurrence; Treatment Outcome; Ursodeoxycholic Acid

2016